Detailansicht

Wissensnetz

Person

Niels Weinhold

Arzt

Name	Niels Weinhold
Ort	Deutschland
Akademischer Grad bzw. Titel	Prof. Dr.
Beruf	Arzt (charakteristischer Beruf) Biologe
Beziehung	University of Arkansas at Little Rock (2014-) Universitätsklinikum Heidelberg. Zentrum für Innere Medizin (11/2018-)
Weitere Angaben	Diss. Naturwissenschaftlich-Mathematische Gesamtfakultät der Univ. Heidelberg Winthrop R. Rockefeller Cancer Institute seit 2014 Dozent an der University of Arkansas for Medical Sciences, USA in Little Rock weiterhin Adjunct Professor seit 1.11.2018: Gruppenleiter in der Sektion Multiples Myelom der Inneren Medizin V der Univ. Heidelberg
Datensatztyp	Person
GND-Nummer	141225688
Datensatz-ID	141225688
Beteiligt an alle anzeigen CD8+ CD28− regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials The landscape of small nucleolar RNA expression in multiple myeloma is determined by cytogenetic alterations High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level Investigation of rare non-coding variants in familial multiple myeloma The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple Myeloma The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states Functional dissection of inherited non-coding variation influencing multiple myeloma risk Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities Reduced splenic uptake on 68Ga-Pentixafor-PET/CT imaging in multiple myeloma - a potential imaging biomarker for disease prognosis Characterization of rare germline variants in familial multiple myeloma Genome-wide association study identifies multiple susceptibility loci for multiple myeloma Selective elimination of immunosuppressive T cells in patients with multiple myeloma A review on tumor heterogeneity and evolution in multiple myeloma: pathological, radiological, molecular genetics, and clinical integration Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS): comparison with multiple myeloma Lack of spleen signal on diffusion weighted MRI is associated with high tumor burden and poor prognosis in multiple myeloma: a link to extramedullary hematopoiesis? Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma Enrichment of B cell receptor signaling and epidermal growth factor receptor pathways in monoclonal gammopathy of undetermined significance: a genome-wide genetic interaction study Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy: Replication of the Reported Candidate Susceptibility Loci Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells Identifizierung und Charakterisierung von Genen, die zwischen dem hyperdiploiden und dem nonhyperdiploiden multiplen Myelom differentiell exprimiert sind

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Niels Weinhold

CD8+ CD28− regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study

Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials

The landscape of small nucleolar RNA expression in multiple myeloma is determined by cytogenetic alterations

High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders

Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level

Investigation of rare non-coding variants in familial multiple myeloma

The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple Myeloma

The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients

An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma

The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states

Functional dissection of inherited non-coding variation influencing multiple myeloma risk

Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities

Reduced splenic uptake on 68Ga-Pentixafor-PET/CT imaging in multiple myeloma - a potential imaging biomarker for disease prognosis

Characterization of rare germline variants in familial multiple myeloma

Genome-wide association study identifies multiple susceptibility loci for multiple myeloma

Selective elimination of immunosuppressive T cells in patients with multiple myeloma

A review on tumor heterogeneity and evolution in multiple myeloma: pathological, radiological, molecular genetics, and clinical integration

Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes

Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS): comparison with multiple myeloma

Lack of spleen signal on diffusion weighted MRI is associated with high tumor burden and poor prognosis in multiple myeloma: a link to extramedullary hematopoiesis?

Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

Enrichment of B cell receptor signaling and epidermal growth factor receptor pathways in monoclonal gammopathy of undetermined significance: a genome-wide genetic interaction study

Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy: Replication of the Reported Candidate Susceptibility Loci

Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells

Identifizierung und Charakterisierung von Genen, die zwischen dem hyperdiploiden und dem nonhyperdiploiden multiplen Myelom differentiell exprimiert sind